Jones Lang LaSalle Inc vs McKesson Corporation — how do they compare? Jones Lang LaSalle Inc trades at $361.02 (market cap $16.72B), while McKesson Corporation trades at $895 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 6.3× Jones Lang LaSalle Inc's market cap, and McKesson Corporation pays a 0.42% dividend while Jones Lang LaSalle Inc pays none. Which is the better fit depends on your goals.
| JLL | MCK | |
|---|---|---|
Market Cap | $16.72B | $105.14B |
Sector | Real Estate | Health |
52-Week High | $373.24 | $995.69 |
52-Week Low | $280.16 | $659.01 |
Enterprise Value | $19.48B | $111.67B |
Dividend Yield | — | 0.42% |
Trailing returns across standard periods
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →